Danaher Co. (DHR) Shares Bought by Cambridge Trust Co.
Cambridge Trust Co. increased its stake in Danaher Co. (NYSE:DHR) by 1.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 159,709 shares of the conglomerate’s stock after purchasing an additional 2,071 shares during the quarter. Cambridge Trust Co.’s holdings in Danaher were worth $21,085,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Vanguard Group Inc grew its stake in Danaher by 1.4% during the 3rd quarter. Vanguard Group Inc now owns 44,738,984 shares of the conglomerate’s stock valued at $4,861,338,000 after acquiring an additional 605,018 shares in the last quarter. BlackRock Inc. grew its stake in Danaher by 0.5% during the 4th quarter. BlackRock Inc. now owns 43,634,997 shares of the conglomerate’s stock valued at $4,499,639,000 after acquiring an additional 207,468 shares in the last quarter. FMR LLC grew its stake in Danaher by 1.4% during the 4th quarter. FMR LLC now owns 22,035,846 shares of the conglomerate’s stock valued at $2,272,336,000 after acquiring an additional 296,095 shares in the last quarter. Geode Capital Management LLC grew its stake in Danaher by 8.4% during the 4th quarter. Geode Capital Management LLC now owns 7,527,142 shares of the conglomerate’s stock valued at $774,743,000 after acquiring an additional 583,194 shares in the last quarter. Finally, Norges Bank purchased a new position in Danaher during the 4th quarter valued at about $747,082,000. 77.59% of the stock is currently owned by hedge funds and other institutional investors.
DHR has been the topic of several research analyst reports. Janney Montgomery Scott lifted their target price on Danaher from $136.00 to $174.00 and gave the company a “buy” rating in a research note on Wednesday, April 17th. Jefferies Financial Group lifted their target price on Danaher to $140.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Needham & Company LLC initiated coverage on Danaher in a research note on Wednesday, January 2nd. They set a “buy” rating and a $114.00 target price on the stock. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a $140.00 target price on shares of Danaher in a research note on Monday, March 4th. Finally, UBS Group lifted their target price on Danaher from $125.00 to $144.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $131.75.
Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.06. Danaher had a return on equity of 11.85% and a net margin of 12.04%. The company had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.80 billion. During the same period in the previous year, the company earned $0.99 earnings per share. The company’s quarterly revenue was up 3.9% compared to the same quarter last year. Equities analysts anticipate that Danaher Co. will post 4.78 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.16. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.54%. Danaher’s payout ratio is 15.04%.
In other news, CAO Robert S. Lutz sold 17,822 shares of the business’s stock in a transaction that occurred on Wednesday, February 27th. The stock was sold at an average price of $126.95, for a total transaction of $2,262,502.90. Following the sale, the chief accounting officer now directly owns 22,251 shares in the company, valued at $2,824,764.45. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO Robert S. Lutz sold 15,000 shares of the business’s stock in a transaction that occurred on Sunday, February 24th. The shares were sold at an average price of $127.00, for a total value of $1,905,000.00. Following the sale, the chief accounting officer now owns 22,251 shares in the company, valued at $2,825,877. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 183,150 shares of company stock valued at $23,279,637. Corporate insiders own 11.40% of the company’s stock.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: Marijuana Stocks Future Looks Bright
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.